Delivery Order SPE2DB22D2005-SPE2DB24FJJE6
- Not listed
- This is a firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,946.55, is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, with a performance period...
- This delivery order, valued at $1,328.82, was awarded on July 31, 2025, to AmerisourceBergen Drug Corp for the supply of AMLOD-VALSA-HCTZ 10-160-12.5MG medication in 30-unit quantities. The contract is funded by the Defense Logistics Agency's Medical Supply Chain and executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This award is structured as a firm fixed-price delivery order with no set-aside...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical wholesaler and distributor. The contract, valued at $10,287.51, is for the supply of the pharmaceutical product Amlod-Valsa-HCTZ 10-320-25 mg in 30-count packages. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 14, 2025, provides for the supply of AMLOD-VALSA-HCTZ 5-160-12.5 mg pharmaceutical products in a 30-count package, with a ceiling value of $2,196.72 and an ultimate completion date of July 15, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense. Performance will be conducted at...
- This is a $3,745.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order was placed against the company's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is for AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,149.97, is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of February 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,347.36, is for the delivery of 4566749432 AMLOD-VALSA-HCTZ 5-160-25 MG 30S, a cardiovascular medication, with a completion date of December 18, 2024. The contract type is Firm Fixed Price. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies under contract 4569914827, valued at $1,024.14 with a firm fixed price structure. The specific delivery involves AMLOD-VALSA-HCTZ 5-160-25 MG 30S, a combination antihypertensive medication, with an ultimate completion date of November 5, 2025. This non-set-aside, competitively awarded delivery order will be performed at AmerisourceBergen's corporate office location in...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,068.10 firm fixed price delivery order contract is for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a cardiovascular medication. The contract has an ultimate completion date of March 13, 2025. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- The Defense Logistics Agency awarded a $1,337.76 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-320-25 MG in a 30-count package. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, due for completion by September 8, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJJE6Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The order is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medication, with a potential value of $1,160.35 and a completion date of February 27, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/26/24 |